Terapia antiblastica per via intrarteriosa del carcinoma della mammella

Translated title of the contribution: Intra-arterial antiblastic treatment of breast carcinoma

Rigoantonio Roversi, Giuseppe Rossi, Stefano Ricci, Marina Roversi, Gianluigi Pinelli, Giovanna Cavallo

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Purpose. To report our personal experience with the locoregional treatment of breast cancer. Material and methods. Eighteen patients aged 33-67 years (mean: 54 years) were treated with 31 sessions of intra-arterial antiblastic infusion, 5 of them for neoadjuvant purposes (Group 1), 5 for palliation in unresectable tumors (Group 2) and 8 for cutaneous recurrences after mastectomy (Group 3). Results. 2/5 CR and 3/5 PR were obtained in Group 1; 2/5 lesions were made resectable and 3/5 RP obtained in stage III or unresectable lesions (Group 2). Finally, 3/8 CR, 3/8 PR, 1/8 SD and 1/8 PD were observed in Group 3. An objective response according to WHO criteria was demonstrated in 15/18 cases (88%). We had no post-treatment hematologic complications, but one patient presented focal subcutaneous sclerosis and one cutaneous necrosis. Conclusions. The morphological efficacy of intraarterial antiblastic infusion in our series was similar to that of other series. No definitive conclusions can be drawn yet about clinical results and long-term survival. This poorly invasive and low risk procedure, which should be combined with other treatments, permits to reduce the extent of surgery and to treat skin recurrences.

Original languageItalian
Pages (from-to)211-216
Number of pages6
JournalRadiologia Medica
Volume95
Issue number3
Publication statusPublished - Mar 1998

Fingerprint

Intra Arterial Infusions
Breast Neoplasms
Skin
Recurrence
Mastectomy
Sclerosis
Necrosis
Therapeutics
Survival
Neoplasms

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

Roversi, R., Rossi, G., Ricci, S., Roversi, M., Pinelli, G., & Cavallo, G. (1998). Terapia antiblastica per via intrarteriosa del carcinoma della mammella. Radiologia Medica, 95(3), 211-216.

Terapia antiblastica per via intrarteriosa del carcinoma della mammella. / Roversi, Rigoantonio; Rossi, Giuseppe; Ricci, Stefano; Roversi, Marina; Pinelli, Gianluigi; Cavallo, Giovanna.

In: Radiologia Medica, Vol. 95, No. 3, 03.1998, p. 211-216.

Research output: Contribution to journalArticle

Roversi, R, Rossi, G, Ricci, S, Roversi, M, Pinelli, G & Cavallo, G 1998, 'Terapia antiblastica per via intrarteriosa del carcinoma della mammella', Radiologia Medica, vol. 95, no. 3, pp. 211-216.
Roversi R, Rossi G, Ricci S, Roversi M, Pinelli G, Cavallo G. Terapia antiblastica per via intrarteriosa del carcinoma della mammella. Radiologia Medica. 1998 Mar;95(3):211-216.
Roversi, Rigoantonio ; Rossi, Giuseppe ; Ricci, Stefano ; Roversi, Marina ; Pinelli, Gianluigi ; Cavallo, Giovanna. / Terapia antiblastica per via intrarteriosa del carcinoma della mammella. In: Radiologia Medica. 1998 ; Vol. 95, No. 3. pp. 211-216.
@article{c63e50a578b5450e921261bb15312acb,
title = "Terapia antiblastica per via intrarteriosa del carcinoma della mammella",
abstract = "Purpose. To report our personal experience with the locoregional treatment of breast cancer. Material and methods. Eighteen patients aged 33-67 years (mean: 54 years) were treated with 31 sessions of intra-arterial antiblastic infusion, 5 of them for neoadjuvant purposes (Group 1), 5 for palliation in unresectable tumors (Group 2) and 8 for cutaneous recurrences after mastectomy (Group 3). Results. 2/5 CR and 3/5 PR were obtained in Group 1; 2/5 lesions were made resectable and 3/5 RP obtained in stage III or unresectable lesions (Group 2). Finally, 3/8 CR, 3/8 PR, 1/8 SD and 1/8 PD were observed in Group 3. An objective response according to WHO criteria was demonstrated in 15/18 cases (88{\%}). We had no post-treatment hematologic complications, but one patient presented focal subcutaneous sclerosis and one cutaneous necrosis. Conclusions. The morphological efficacy of intraarterial antiblastic infusion in our series was similar to that of other series. No definitive conclusions can be drawn yet about clinical results and long-term survival. This poorly invasive and low risk procedure, which should be combined with other treatments, permits to reduce the extent of surgery and to treat skin recurrences.",
keywords = "Breast cancer, intra-arterial infusion, Breast, cancer",
author = "Rigoantonio Roversi and Giuseppe Rossi and Stefano Ricci and Marina Roversi and Gianluigi Pinelli and Giovanna Cavallo",
year = "1998",
month = "3",
language = "Italian",
volume = "95",
pages = "211--216",
journal = "Radiologia Medica",
issn = "0033-8362",
publisher = "Springer-Verlag Italia s.r.l.",
number = "3",

}

TY - JOUR

T1 - Terapia antiblastica per via intrarteriosa del carcinoma della mammella

AU - Roversi, Rigoantonio

AU - Rossi, Giuseppe

AU - Ricci, Stefano

AU - Roversi, Marina

AU - Pinelli, Gianluigi

AU - Cavallo, Giovanna

PY - 1998/3

Y1 - 1998/3

N2 - Purpose. To report our personal experience with the locoregional treatment of breast cancer. Material and methods. Eighteen patients aged 33-67 years (mean: 54 years) were treated with 31 sessions of intra-arterial antiblastic infusion, 5 of them for neoadjuvant purposes (Group 1), 5 for palliation in unresectable tumors (Group 2) and 8 for cutaneous recurrences after mastectomy (Group 3). Results. 2/5 CR and 3/5 PR were obtained in Group 1; 2/5 lesions were made resectable and 3/5 RP obtained in stage III or unresectable lesions (Group 2). Finally, 3/8 CR, 3/8 PR, 1/8 SD and 1/8 PD were observed in Group 3. An objective response according to WHO criteria was demonstrated in 15/18 cases (88%). We had no post-treatment hematologic complications, but one patient presented focal subcutaneous sclerosis and one cutaneous necrosis. Conclusions. The morphological efficacy of intraarterial antiblastic infusion in our series was similar to that of other series. No definitive conclusions can be drawn yet about clinical results and long-term survival. This poorly invasive and low risk procedure, which should be combined with other treatments, permits to reduce the extent of surgery and to treat skin recurrences.

AB - Purpose. To report our personal experience with the locoregional treatment of breast cancer. Material and methods. Eighteen patients aged 33-67 years (mean: 54 years) were treated with 31 sessions of intra-arterial antiblastic infusion, 5 of them for neoadjuvant purposes (Group 1), 5 for palliation in unresectable tumors (Group 2) and 8 for cutaneous recurrences after mastectomy (Group 3). Results. 2/5 CR and 3/5 PR were obtained in Group 1; 2/5 lesions were made resectable and 3/5 RP obtained in stage III or unresectable lesions (Group 2). Finally, 3/8 CR, 3/8 PR, 1/8 SD and 1/8 PD were observed in Group 3. An objective response according to WHO criteria was demonstrated in 15/18 cases (88%). We had no post-treatment hematologic complications, but one patient presented focal subcutaneous sclerosis and one cutaneous necrosis. Conclusions. The morphological efficacy of intraarterial antiblastic infusion in our series was similar to that of other series. No definitive conclusions can be drawn yet about clinical results and long-term survival. This poorly invasive and low risk procedure, which should be combined with other treatments, permits to reduce the extent of surgery and to treat skin recurrences.

KW - Breast cancer, intra-arterial infusion

KW - Breast, cancer

UR - http://www.scopus.com/inward/record.url?scp=2542480097&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2542480097&partnerID=8YFLogxK

M3 - Articolo

C2 - 9638168

AN - SCOPUS:2542480097

VL - 95

SP - 211

EP - 216

JO - Radiologia Medica

JF - Radiologia Medica

SN - 0033-8362

IS - 3

ER -